Key statistics
As of last trade Immuron Ltd (ANWA:STU) traded at 0.61, 7.96% above its 52-week low of 0.565, set on Feb 13, 2026.
52-week range
| Open | 0.565 |
|---|---|
| High | 0.635 |
| Low | 0.565 |
| Bid | 0.61 |
| Offer | 0.685 |
| Previous close | 0.585 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 8.17m |
| Free float | 8.17m |
| P/E (TTM) | -- |
| Market cap | 6.48m USD |
| EPS (TTM) | -0.6391 USD |
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Announcements
- Immuron Reports Continued Sales Growth
- Immuron New U.S. Department of Defense Award & Clinical Trial Update
- Immuron IMM-529 IND approved by FDA
- Immuron Announces Clinical Trial Update
- Immuron Q1 FY26 YoY growth
- Immuron Submits IMM-529 IND to FDA
- Immuron Letter to Shareholders – Projects Update
- Immuron partners with InvestorHub
- Immuron - FY25 global sales exceed projection, up 49% on prior year
- Immuron Letter to Shareholders: Projects Update
More ▼
